Treatment

MVA-209-FSP high dose clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1, PHASE2
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
This study is testing a new ‘genetic vaccine’ alongside an existing cancer drug (Keytruda®) for adults with certain advanced cancers. It aims to see if the combination is safe, how the body reacts to it, and if it helps shrink tumours.
For: Solid Tumor, Adult
United States · Belgium · Canada